SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-060295
Filing Date
2021-05-03
Accepted
2021-05-03 17:01:16
Documents
17
Period of Report
2021-05-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2114980d1_8k.htm   iXBRL 8-K 36179
2 EXHIBIT 4.1 tm2114980d1_ex4-1.htm EX-4.1 76084
3 EXHIBIT 10.1 tm2114980d1_ex10-1.htm EX-10.1 330675
4 EXHIBIT 10.2 tm2114980d1_ex10-2.htm EX-10.2 109327
5 EXHIBIT 99.1 tm2114980d1_ex99-1.htm EX-99.1 10496
9 GRAPHIC tm2114980d1_ex99-1img001.jpg GRAPHIC 4615
  Complete submission text file 0001104659-21-060295.txt   860279

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA ettx-20210503.xsd EX-101.SCH 3190
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE ettx-20210503_lab.xml EX-101.LAB 34592
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ettx-20210503_pre.xml EX-101.PRE 22713
10 EXTRACTED XBRL INSTANCE DOCUMENT tm2114980d1_8k_htm.xml XML 3610
Mailing Address 35 GATEHOUSE DRIVE WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE WALTHAM MA 02451 (781) 810-0120
Entasis Therapeutics Holdings Inc. (Filer) CIK: 0001724344 (see all company filings)

IRS No.: 824592913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38670 | Film No.: 21884472
SIC: 2834 Pharmaceutical Preparations